Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Ttk Healthcare
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

TTK Healthcare

WEBSITE BSE:507747 NSE: TTKHLTCARE Inc. Year: 1958 Industry: Diversified My Bucket: Add Stock

₹872.8 16.9 | 2%

Last updated: 15:48

Consolidated Standalone

Last updated: 15:48

TTK Healthcare Overview

TTK Healthcare Ltd is engaged in pharmaceuticals, customer products, medical devices and foods agencies. It's segments include Medical Devices, Consumer Products, Pharmaceuticals, Foods and Others. Its Pharmaceuticals phase includes merchandise for both human and veterinary use. It additionally includes over the counter brands, such as Woodward's Gripewater allotted with the aid of the Consumer Products division. The Woodward's Gripe Water brand offers products inside the baby care category. The Medical Devices segment includes Artificial Heart...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

TTK Healthcare Key Financials

Market Cap ₹1233 Cr.

Stock P/E 15.1

P/B 1.1

Current Price ₹872.8

Book Value ₹ 772.2

Face Value 10

52W High ₹1402

Dividend Yield 1.15%

52W Low ₹ 737

Edit Ratio

TTK Healthcare Share Price

₹ | |

Volume
Price

TTK Healthcare Quarterly Price

Quarterly Monthly
Show Value Show %

TTK Healthcare Peer Comparison

TTK Healthcare Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 186 184 181 208 198 205 190 226 204 209
Other Income 16 16 16 17 18 18 19 18 19 17
Total Income 202 200 197 225 216 223 209 244 223 227
Total Expenditure 176 179 169 201 190 197 178 224 198 202
Operating Profit 26 21 28 24 26 26 31 21 24 25
Interest 1 0 1 1 1 1 1 1 1 1
Depreciation 3 3 3 2 2 2 2 2 2 2
Exceptional Income / Expenses 0 0 0 20 0 0 -6 0 0 -8
Profit Before Tax 22 18 24 41 23 23 22 18 21 14
Provision for Tax 6 5 6 9 6 6 6 5 1 4
Profit After Tax 16 13 18 32 17 17 16 13 20 11
Adjustments -0 -0 0 0 0 -0 0 0 -0 0
Profit After Adjustments 16 13 18 32 17 17 16 13 20 11
Adjusted Earnings Per Share 11.3 9.1 12.9 22.3 12.2 11.8 11.4 9.2 14.4 7.5

TTK Healthcare Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 483 519 528 578 628 646 476 599 725 753 801 829
Other Income 7 6 6 8 8 9 10 16 48 63 71 73
Total Income 489 524 534 585 636 655 486 616 773 815 873 903
Total Expenditure 453 478 489 535 578 617 457 577 694 715 767 802
Operating Profit 36 46 44 50 57 37 29 38 80 100 106 101
Interest 4 3 3 5 3 3 2 3 5 3 3 4
Depreciation 6 7 12 15 15 14 13 13 13 13 8 8
Exceptional Income / Expenses 0 0 0 0 0 0 8 2 0 0 14 -14
Profit Before Tax 26 36 29 30 39 19 23 25 62 84 108 75
Provision for Tax 10 13 10 12 15 7 -14 6 17 21 27 16
Profit After Tax 16 23 19 18 24 12 37 19 45 63 82 60
Adjustments 0 0 0 0 0 0 10 23 595 0 0 0
Profit After Adjustments 16 23 19 18 24 12 46 42 640 63 82 60
Adjusted Earnings Per Share 20.8 29.2 24.1 12.9 17.2 8.7 26 13.1 31.6 44.5 57.8 42.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 6% 10% 4% 5%
Operating Profit CAGR 6% 41% 23% 11%
PAT CAGR 30% 63% 47% 18%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -30% -12% 12% -1%
ROE Average 8% 7% 8% 10%
ROCE Average 11% 10% 9% 14%

TTK Healthcare Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 118 136 157 233 251 249 295 330 953 1001 1065
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 16 1 1 1 0 0 0 0 0 0 0
Other Non-Current Liabilities 12 15 7 2 2 7 4 1 2 -2 -1
Total Current Liabilities 129 150 120 168 157 172 189 199 211 202 211
Total Liabilities 275 303 285 403 411 427 488 551 1166 1201 1275
Fixed Assets 52 106 99 110 98 89 85 80 71 75 81
Other Non-Current Assets 57 13 19 38 42 40 27 22 28 49 90
Total Current Assets 166 184 167 256 272 298 375 425 1066 1077 1104
Total Assets 275 303 285 403 411 427 488 551 1166 1201 1275

TTK Healthcare Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 84 77 19 19 15 11 8 10 15 9 11
Cash Flow from Operating Activities 39 37 18 25 17 20 96 45 -25 -5 -4
Cash Flow from Investing Activities -49 -27 5 -23 10 -13 -77 -30 32 28 20
Cash Flow from Financing Activities 3 -11 -23 -7 -31 -10 -17 -10 -12 -22 -18
Net Cash Inflow / Outflow -7 -0 0 -4 -4 -4 2 5 -6 2 -2
Closing Cash & Cash Equivalent 77 77 19 15 11 8 10 15 9 11 9

TTK Healthcare Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 20.8 29.19 24.13 12.86 17.25 8.72 26.03 13.1 31.61 44.47 57.79
CEPS(Rs) 28.71 38.47 39.47 23.64 27.63 18.89 35.24 22.01 40.67 53.71 63.69
DPS(Rs) 4.5 5 5 5 5 3 6 10 10 10 10
Book NAV/Share(Rs) 146.54 169.71 197.09 161.75 174.81 173.09 205.4 230.16 671.59 705.23 750.61
Core EBITDA Margin(%) 6.12 7.8 7.29 7.37 7.89 4.38 4.06 3.64 4.17 4.72 4.22
EBIT Margin(%) 6.2 7.49 6.12 6.04 6.79 3.51 5.11 4.69 8.9 10.98 13.52
Pre Tax Margin(%) 5.45 6.84 5.53 5.22 6.25 3.01 4.75 4.14 8.2 10.63 13.12
PAT Margin (%) 3.34 4.37 3.55 3.15 3.88 1.91 7.73 3.09 5.94 7.94 9.89
Cash Profit Margin (%) 4.61 5.75 5.81 5.78 6.22 4.13 10.46 5.19 7.65 9.59 10.9
ROA(%) 6.27 7.85 6.38 5.28 5.99 2.94 8.04 3.56 5.2 5.31 6.6
ROE(%) 14.94 18.46 13.16 9.52 10.25 5.01 13.76 6.02 7.01 6.46 7.94
ROCE(%) 20.71 23.85 18.63 15.42 15.46 8.28 8.38 8.59 10.13 8.72 10.63
Receivable days 31.24 32 27.96 28.31 39.41 44.37 52.35 34.52 35.37 41.18 39.11
Inventory Days 26.94 27.71 29.42 30.5 31.45 35.88 54.42 45.45 39.69 41.87 45.43
Payable days 49.91 50.5 75.03 115.6 110.54 111.76 160.52 130.35 112.47 114.99 103.44
PER(x) 44.71 31.69 32.85 81.86 39.34 37.5 19 63.29 32.71 33.35 20.72
Price/Book(x) 6.35 5.45 4.02 6.51 3.88 1.89 2.41 3.6 1.54 2.1 1.59
Dividend Yield(%) 0.48 0.54 0.63 0.48 0.74 0.92 1.21 1.21 0.97 0.67 0.84
EV/Net Sales(x) 1.42 1.31 1.06 2.42 1.37 0.55 1.03 1.53 0.88 1.78 1.16
EV/Core EBITDA(x) 19.01 14.76 12.6 27.9 15.04 9.66 16.71 24.06 8.03 13.43 8.74
Net Sales Growth(%) 16.04 7.44 1.72 9.42 8.72 2.85 -26.28 25.88 21.01 3.82 6.47
EBIT Growth(%) 32.33 29.62 -16.89 8 22.26 -46.78 7.22 15.38 138.2 29.91 28.52
PAT Growth(%) 30.4 40.3 -17.32 -3.07 34.18 -49.46 198.57 -49.68 141.32 40.69 29.94
EPS Growth(%) 30.4 40.3 -17.32 -46.72 34.18 -49.46 198.57 -49.68 141.31 40.69 29.94
Debt/Equity(x) 0.37 0.29 0.15 0.21 0.12 0.12 0.06 0.06 0.03 0.02 0.02
Current Ratio(x) 1.29 1.22 1.39 1.53 1.73 1.74 1.99 2.13 5.06 5.35 5.23
Quick Ratio(x) 1 0.95 1.03 1.21 1.38 1.32 1.62 1.74 4.66 4.86 4.72
Interest Cover(x) 8.23 11.68 10.37 7.37 12.62 6.94 14.22 8.67 12.77 31.53 33.59
Total Debt/Mcap(x) 0.06 0.05 0.04 0.03 0.03 0.06 0.03 0.02 0.02 0.01 0.01

TTK Healthcare Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56
FII 0 0 0 0 0 0 0 0 0 0
DII 4.98 2.98 3 3.04 3.04 3.04 3.07 3.08 2.97 3.01
Public 20.45 22.45 22.43 22.4 22.4 22.4 22.37 22.36 22.46 22.43
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

TTK Healthcare News

TTK Healthcare Pros & Cons

Pros

  • Company has delivered good profit growth of 46% CAGR over last 5 years
  • Debtor days have improved from 114.99 to 103.44days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 7% over the last 3 years.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!